معرفی
Carola Boost is a researcher at the Department of Pharmacology and Toxicology, University of Cologne, and a core member of the Research Group Translational Research in Psychosis. Her work bridges molecular pharmacology and clinical psychiatry to investigate biological mechanisms underlying psychotic disorders.
Her research focuses on:
- Endocannabinoid system dysregulation in psychosis
- Neurobiological effects of cannabinoids (CBD/THC)
- Translational models of adolescent brain development
- Neuroimaging biomarkers for psychiatric conditions
- Clinical pharmacology of cannabinoid therapeutics
- Molecular pathways in schizophrenia spectrum disorders
Analysis of her publication record reveals a concentrated trajectory in cannabinoid neuroscience, with recent work (2024) examining dose-dependent pharmacokinetics of cannabis compounds in humans, building upon foundational neurobiological studies (2015) of cannabinoid receptor function in adolescent behavior models. This demonstrates consistent specialization in bridging molecular mechanisms with clinical psychiatric applications.
She operates within the Research Group Translational Research in Psychosis, which integrates basic pharmacological research with clinical psychiatry through collaborations between the University of Cologne and mental health institutions like the Central Institute of Mental Health (ZI).
